Medical Science Test 2 Nddc Scholarship

Affinity describes the tendency or 'attractiveness' of a drug to bind to a specific receptor. It is governed by the chemical forces (such as van der Waals forces, hydrogen bonds, and ionic bonds) that facilitate the association between the drug molecule and the receptor's binding site. A drug with high affinity will bind tightly to the receptor even at low concentrations. This is distinct from efficacy (Option B), which is the drug's ability to actually initiate a biological change once the binding has occurred.

Acetylcholine (ACh) is the primary neurotransmitter of the parasympathetic nervous system and the somatic nervous system. It acts on two main types of receptors: nicotinic and muscarinic. Nicotinic receptors are ligand-gated ion channels located at the neuromuscular junction (triggering muscle contraction), in all autonomic ganglia, and in the central nervous system. When acetylcholine binds to these receptors, it causes a rapid change in membrane permeability to ions like sodium and potassium.

Nicotinic receptors are found in three main locations: the motor endplates of skeletal muscle (neuromuscular junctions), all autonomic ganglia (both sympathetic and parasympathetic), and certain regions of the brain. In the ganglia and at the neuromuscular junction, they are located on the postsynaptic membrane, where they respond to acetylcholine released from the pre-ganglionic or motor neurons to propagate the signal. Parasympathetic neuroeffector junctions (Option A) typically utilize muscarinic receptors instead.

In pharmacology, it is a fundamental rule that only 'free' (unbound) drug molecules are pharmacologically active and capable of diffusing across membranes to reach their target receptors. When a drug is bound to plasma proteins like albumin, it is essentially in a storage state and cannot produce an effect. As the free drug is metabolized or eliminated, the drug-protein complex dissociates to release more free drug. Therefore, the statement that a drug 'can only act when in a drug-protein complex' is completely false, as the complex itself is inactive.